Study Start-up Clinical Research Associate

Job Description Summary

#LI-Hybrid

Location : Sydney, Australia

About the Role

The Study Start-Up CRA is accountable for site selections as well as study-specific start-up activities and deliverables of assigned sites for Phase I-IV GDD trials within the country in adherence with monitoring procedures and processes in accordance with ICH / GCP, local regulations and SOPs.

Proactive site preparation and early identification of real site needs and issues and close handover to execution CRA for all sites is key (from issue management to risk identification).

Job Description

Key Responsibilities

• Supports country SSU strategy in close collaboration with SSO Study Start-Up Team Lead, SSO Study Start-Up Manager, SSO Feasibility Manager and SSO Site Partnership Manager.
• Collaborates with SSO Study Start-Up Manager, SSO Study Start-Up Team Lead and global study team to ensure Study Start-Up timelines and deliverables are met according to country commitments.
• Accountable for timely start-up activities from country allocation until site greenlight at assigned sites.
• Conducts site selection visits, verifies site eligibility for a specific study. Main contact for trial sites during site selection, study start-up and IRB / IEC and HA submission preparation, ensuring that milestones (KPIs) and time schedule for study start-up are met as planned. Facilitates the preparation and collection of site and country-level documents.
• Collects submission relevant site-specific documents for all relevant site personnel within agreed timelines. Supports SSU Manager in preparation of country-specific documents, e.g. ICF, patient-facing materials, etc. Supports SSO Study Start-Up Manager and assigned sites in vendor set-up activities.
• Prepare and finalize site-specific documents for submission. Negotiates investigator payments as needed. Supports preparation of financial contracts between Novartis and investigational sites and investigators as needed. Updates all systems until site Green Light on an ongoing basis. Supports preparation of audits and inspections as applicable. Supports reduction of formal site-specific IRB / IEC deficiencies.
• Ensures timelines, accuracy, and quality of country and site TMF documents in study start-up to ensure TMF inspection readiness. Ensures adherence to financial standards, prevailing legislation, ICH / GCP, IRB / IEC, Health Authority and SOP requirements. Implements innovative and efficient processes which are in line with Novartis strategy. Ensures sites are prepared for “Green Light” and is accountable to send the Green Light to SSU Manager for review and approval.

Essential Requirements

Commitment to Diversity and Inclusion / EEO paragraph : Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.

Skills Desired

Clinical Trials, Conflict Management, Contract Management, Effective Communication, Financial Analysis, Negotiation Skills

#J-18808-Ljbffr